HLA

Detailed Immune Gene Study of Long COVID Shows HLA-B*15 May Offer Protection

Updated

Abstract

Among 168 patients with Long COVID, the HLA-B*15 serotype was significantly less frequent, suggesting a potential protective factor.

  • The study involved 453 hospitalized patients with confirmed SARS-CoV-2 infection.
  • Logistic regression identified HLA-B*15 as independently associated with a reduced risk of Long COVID symptoms.
  • No significant associations were found for several other immunogenetic markers, including HLA-C and CCR5 variants.
  • The conserved extended haplotype CEH 44.2 was less frequent in Long COVID patients but did not remain significant after further adjustments.
  • Findings suggest a potential role for HLA-mediated antiviral immunity in influencing Long COVID susceptibility.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free